Andrew Tutt
Author
Institutions Breast Cancer Now, Institute of Cancer Research
Past institutions Breast Cancer Now, Institute of Cancer Research, King's College London, Response Biomedical (Canada), Target (United States) +5 more
ORCID: Yes
H-index: 99
I10-index: 207
Works count: 735
Citations count: 76,890
Signatures of mutational processes in human cancer
2013 · Ludmil B. Alexandrov, Serena Nik‐Zainal, et al. · Nature
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 · Hannah Farmer, Nuala McCabe, et al. · Nature
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
2009 · Peter C.C. Fong, David S. Boss, et al. · New England Journal of Medicine
74.4%
505
| PARP inhibition in cancer therapy | 80 |
| Cancer Genomics and Diagnostics | 58 |
| Cancer Immunotherapy and Biomarkers | 47 |
| BRCA gene mutations in cancer | 43 |
| Breast Cancer Treatment Studies | 37 |
| article | 291 |
| preprint | 254 |
| supplementary-materials | 64 |
| review | 30 |
| letter | 10 |